taking semaglutide and tirzepatide together vs Tirzepatide, which is better for you? Switching from Semaglutide to Tirzepatide

6 CT-868, an investigational, once-daily, subcutaneously injected dual GLP-1/GIP receptor agonist currently in Phase II with the potential to be a first in class treatment for glycaemic control as an adjunct to insulin in patients living with type 1 diabetes

Their rapid adoption reflects substantial demand tirzepatide is currently the single most-searched peptide-related term online, with roughly 1 million monthly searches, and weight-management compounds account for the majority of peptide search traffic

Nicholls SJ, Tofe S, le Roux CW, DAlessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC

Strehl, C., Bijlsma, J

Women-focused GLP-1 platform with expert coaching and personalized support

Rest: Give your body time to heal by getting adequate sleep and avoiding strenuous activity